NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Assets Average (2021 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Assets Average came in at $1.4 million in Q4 2025, down 51.21% year-over-year from $2.8 million in Q4 2024, and down 56.67% quarter-over-quarter from $3.1 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Assets Average (2021 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Assets Average across 5 years of filings, most recently posting $1.4 million for Q4 2025.

  • In Q4 2025, Assets Average fell 51.21% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (down 51.21% YoY), while the FY2025 annual figure was $2.8 million, down 27.8% from the prior year.
  • Assets Average came in at $1.4 million for Q4 2025 at NeuroSense Therapeutics, down from $3.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $12.9 million in Q2 2022 to a low of $1.4 million in Q4 2025.
  • Average Assets Average over 5 years is $5.8 million, with a median of $6.1 million recorded in 2021.
  • Year-over-year, Assets Average tumbled 78.69% in 2024 and jumped 90.42% in 2025.
  • Over 5 years, Assets Average stood at $6.1 million in 2021, then jumped by 38.8% to $8.5 million in 2022, then slumped by 49.42% to $4.3 million in 2023, then tumbled by 35.14% to $2.8 million in 2024, then plunged by 51.21% to $1.4 million in 2025.
  • Per Business Quant data, the three most recent Assets Average figures were $1.4 million in Q4 2025, $3.1 million in Q2 2025, and $2.8 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 41.30 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 11.22 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 5.51 Bn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.36 Mn
Jun 30, 2025 3.13 Mn
Dec 31, 2024 2.78 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 1.64 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 4.29 Mn
Sep 30, 2023 6.63 Mn
Jun 30, 2023 6.60 Mn
Mar 31, 2023 6.53 Mn
Dec 31, 2022 8.47 Mn
Sep 30, 2022 10.34 Mn
Jun 30, 2022 12.91 Mn
Mar 31, 2022 12.89 Mn
Dec 31, 2021 6.11 Mn
API Access

NeuroSense Therapeutics Assets Average API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets-average&ticker=NRSN&period=max&api_key=YOUR_API_KEY